Literature DB >> 17003000

Doping: a challenge to the endocrinologist. A reappraisal in view of the Olympic Games of 2004.

Leonidas H Duntas1, Constantinos Parisis.   

Abstract

The aim of this review is to provide an update on drug abuse by athletes, their mode of action and the technical difficulties of detection. The most common doping agents are the anabolic steroids (AS), testosterone derivatives modified to take advantage of the anabolic rather than the androgenic properties of the hormone. However, there are numerous side-effects that discourage their use. Several other substances and hormones, GH and rhEPO are currently used alone or combined to enhance performance. The diversity in nature of the substances used requires a constant alertness of physicians to detect drug abuse in sports. Doping is not limited to the professional athletes. It seems to be a generalized phenomenon that reflects modern society's concept of success. Therefore, the campaign to eradicate doping must also focus on individual responsibility. Since modern-day doping is strongly related to hormonal preparations, endocrinologists may play a pivotal role in providing information, protecting athletes' health and, moreover, retaining the ethical value of sport.

Entities:  

Year:  2003        PMID: 17003000     DOI: 10.14310/horm.2002.1180

Source DB:  PubMed          Journal:  Hormones (Athens)        ISSN: 1109-3099            Impact factor:   2.885


  4 in total

Review 1.  Hormones as doping in sports.

Authors:  Leonidas H Duntas; Vera Popovic
Journal:  Endocrine       Date:  2012-09-19       Impact factor: 3.633

2.  A simple and rapid ESI-LC-MS/MS method for simultaneous screening of doping agents in urine samples.

Authors:  I Madhusudhana Reddy; Alka Beotra; S Jain; S Ahi
Journal:  Indian J Pharmacol       Date:  2009-04       Impact factor: 1.200

3.  Lipid Profile Changes Induced by Chronic Administration of Anabolic Androgenic Steroids and Taurine in Rats.

Authors:  A E Rosca; Camelia Sorina Stancu; Corin Badiu; Bogdan Ovidiu Popescu; Radu Mirica; Constantin Căruntu; Serban Gologan; Suzana Elena Voiculescu; Ana-Maria Zagrean
Journal:  Medicina (Kaunas)       Date:  2019-08-27       Impact factor: 2.430

4.  Gene expression in hair follicle dermal papilla cells after treatment with stanozolol.

Authors:  M Reiter; M W Pfaffl; M Schönfelder; H H D Meyer
Journal:  Biomark Insights       Date:  2008-12-23
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.